About this data
What it is
The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
Who files it
The USPTO publishes each grant.
How current
Grants are published every Tuesday, and we collect them weekly.
Worth knowing
A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.

All of this comes from public filings.

Patents granted per week, last 12 weeks

05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10
05,00010.0K15.0KAug 25 · Patents granted: 8,093Aug 25Sep 1 · Patents granted: 6,519Sep 1Sep 8 · Patents granted: 6,822Sep 8Sep 15 · Patents granted: 6,983Sep 15Sep 22 · Patents granted: 5,563Sep 22Sep 29 · Patents granted: 6,286Sep 29Oct 6 · Patents granted: 7,272Oct 6Oct 13 · Patents granted: 8,528Oct 13Oct 20 · Patents granted: 7,948Oct 20Oct 27 · Patents granted: 5,467Oct 27Nov 3 · Patents granted: 10,067Nov 3Nov 10 · Patents granted: 8,414Nov 10

Latest patent grants

Reset

Showing: ticker RXRX

Latest patent grants
GrantedPatentOwnerTypeSource
Nov 3, 202612784478
Utilizing contrastive machine learning models to extract joint-space…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Oct 6, 202612755813
Generating virtual perturbed cells utilizing a latent transfer pertur…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 15, 202612738081
Utilizing machine learning and digital embedding processes to generat…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 15, 202612737284
Detecting analysis model compatibilities with complex experiment desi…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Sep 8, 202612729201
MALT-1 modulators
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jun 23, 202612663916
Methods and user interfaces for designing cell-based screening assay…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jun 16, 202612657939
Utilizing machine learning models to synthesize perturbation data to…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jun 9, 202612651432
Utilizing machine learning models to synthesize perturbation data to…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jun 2, 202612645878
Utilizing language machine learning models for autonomous executions…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
May 26, 202612640230
Active learning for discovering pairwise interactions via representat…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Apr 21, 202612609186
Techniques for data-enabled drug discovery
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Mar 10, 202612572849
Image embeddings via deep learning and adaptive batch normalization
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Feb 3, 202612540149
Aromatic heterocyclic compound, pharmaceutical composition, and use t…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jan 27, 202612533356
Pyrazolopyrimidine compounds as adenosine receptor antagonists
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jan 20, 202612528779
Heterocyclic compounds and related methods
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jan 13, 202612525324
Active learning using coverage score
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Dec 9, 202512494266
Utilizing a clinical-phenomics causal discovery framework to generate…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 4, 202512462903
Utilizing compound-protein machine learning representations to genera…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 4, 202512462899
Utilizing compound-protein machine learning representations to genera…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Nov 4, 202512461091
Systems and methods for discriminating effects on targets
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Aug 19, 202512395408
Orchestration interface system for coordinating complex compound disc…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jul 29, 202512374429
Utilizing machine learning models to synthesize perturbation data to…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jul 29, 202512373950
Training and utilizing machine learning models to generate perturbati…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Jul 1, 202512346289
Cross-platform flexible data model for dynamic storage, management, a…
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
May 13, 202512300360
Preemptible-based scaffold hopping
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗
Dec 17, 202412170135
Systems and methods for evaluating query perturbations
RXRX
Recursion Pharmaceuticals, Inc.
utilityGoogle Patents ↗

26 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:35 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances